SCHEMBL17601979

SCHEMBL17601979

C=Cc1cccc2c1N(C)Cc1cc(OCc3ccccc3)c(OCc3ccccc3)cc1-2

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 2/20 0.43
PDE4B Q07343 1/20 0.37
HTR2A P28223 2/20 0.37
HTR2C P28335 2/20 0.37
HTR2B P41595 2/20 0.37
HTR1A P08908 1/20 0.37
HTR7 P34969 1/20 0.37
PTGER1 P34995 1/20 0.36
PTGER4 P35408 1/20 0.36
PTGER3 P43115 1/20 0.36
PTGER2 P43116 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
BRD4 O60885 1/20 0.36
ACHE P22303 1/20 0.36
HTT P42858 1/20 0.35
CARM1 Q86X55 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17602005 0.88 CARM1 (0.40) MAPTMAPK1CARM1
SCHEMBL22761235 0.87 ACHE (0.38) CHRNA7ACHE
SCHEMBL22761232 0.86 ACHE (0.38) HTR2AHTR2CMAPTACHEHTT
SCHEMBL17601999 0.85 ADRA2A (0.41) PDE4BHTR2AHTR2CHTR2BHTR1A
SCHEMBL22761237 0.83 ACHE (0.36) PDE4BHTR2AHTR2CHTR2BHTR1A
SCHEMBL16002508 0.82 HTR1A (0.36) PDE4BHTR2AHTR1AACHE
SCHEMBL22271831 0.82 ACHE (0.52) MAPTMAPK1ACHEHTT
SCHEMBL15993833 0.82 CHRNA7 (0.47) CHRNA7PDE4BHTR2AHTR2CHTR2B
SCHEMBL17601996 0.81 ABCB1 (0.40) CHRNA7HTR2AHTR2CHTR2BHTR1A
SCHEMBL22760876 0.81 ACHE (0.40) ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9682954-B2 Phenanthridine derivatives, preparation methods and uses thereof KUNMING INSTITUTE OF BOTANY, THE CHINESE ACADEMY OF SCIENCES (CN) 2017-06-20 US claimed
US-20160083364-A1 Phenanthridine Derivatives, Preparation Methods and Uses Thereof CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACADEMY OF SCIENCES (CN) 2016-03-24 US claimed
US-9682954-B2 Phenanthridine derivatives, preparation methods and uses thereof KUNMING INSTITUTE OF BOTANY, THE CHINESE ACADEMY OF SCIENCES (CN) 2017-06-20 US disclosed
CN-103145617-B Phenanthridines analog derivative and pharmaceutical composition thereof and its preparation method and application KUNMING INSTITUTE OF BOTANY, CHINESE ACADEMY OF SCIENCES (CN) 2016-04-06 CN disclosed
US-20160083364-A1 Phenanthridine Derivatives, Preparation Methods and Uses Thereof CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACADEMY OF SCIENCES (CN) 2016-03-24 US disclosed
CN-103145617-A Phenanthridine derivative as well as medicinal composition, preparation method and application thereof KUNMING INST BOTANY CN ACAD 2013-06-12 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160083364-A1 Phenanthridine Derivatives, Preparation Methods and Uses Thereof CTNNB1, WNT3A, WNT1 CHRNA7 3354/4885PDE4B 3710/4885HTR2A 1587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.